The ABPI has launched an industry partnership guideline to guide interactions between the pharmaceutical industry and the NHS when collaborating on joint projects.
This collaboration could take the form of pooling skills, experience and resources for the benefit of patients, such as helping to improve adherence to medication.
ABPI chief executive, Mike Thompson, commented that:
“Benefits of joint working are significant for all concerned – higher quality care, lower hospital admissions and more appropriate use of medicines”
“[We hope the guidance will] give people in companies and the NHS the confidence to work together in new ways, and kickstart many successful new joint working projects.”
The legal guidance will also help all concerned to comply with data protection and competition laws, and projects will be underpinned by a formal Joint Working Agreement.
Read more on this story here.